Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double-blind placebo-controlled trial
Pankaj Hari(Indian Council of Medical Research), Arvind Bagga(All India Institute of Medical Sciences), Arti Kapil(Hindu Rao Hospital), Smriti Hari(All India Institute of Medical Sciences), Aditi Sinha, Rakesh Kumar(The University of Texas MD Anderson Cancer Center), Ravindra Mohan Pandey(Dignity Health)
Cited by 61
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2009|176